Zimmer Biomet (NYSE: ZBH) is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001 Zimmer was spun off from Bristol-Myers Squibb and began trading on the New York ...
Leading medical device manufacturers, Zimmer and Biomet, join to offer innovative orthopedic medical devices and joint replacement. Welcome to Zimmer Biomet.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. See More · Watch the Video ...
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Americas Spine, Office Based Technologies, Craniomaxillofacial and ...
Company profile & key executives for Zimmer Biomet Holdings Inc (ZBH:New York) including description, corporate address, management team and contact info.
Stock analysis for Zimmer Biomet Holdings Inc (ZBH:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Apr 5, 2017 ... Zimmer Inc. company research & investing information. ... Zimmer Inc., doing business as Zimmer Biomet, designs, manufactures, and markets joint replacement technologies. It offers knee, hip, and ... CEO, President, Director, CEO of Zimmer Holdings Inc and President of Zimmer Holdings Inc. Age: 53.
Jun 24, 2015 ... In connection with the combination, Zimmer has changed its corporate name to Zimmer Biomet Holdings, Inc. The Company will trade on the New York Stock Exchange and the SIX Swiss Exchange under the ticker symbol ZBH beginning June 29, 2015. "The coming together of Zimmer and Biomet is a ...
Aug 20, 2015 ... Medical device company Zimmer Holdings, Inc. agreed to divest U.S. rights and assets related to unicondylar knee implants, total elbow implants, and bone cement in order to settle FTC charges that its proposed $13.35 billion acquisition of Biomet Inc. is anticompetitive. According to the complaint, Zimmer ...